505 related articles for article (PubMed ID: 31148490)
1. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
[No Abstract] [Full Text] [Related]
2. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of different photoprotection strategies in preventing actinic keratosis new lesions after photodynamic therapy. The ATHENA study: a two-center, randomized, prospective, assessor-blinded pragmatic trial.
Pavone PS; Lovati S; Scarcella G; Milani M
Curr Med Res Opin; 2019 Jan; 35(1):141-145. PubMed ID: 30404544
[No Abstract] [Full Text] [Related]
4. Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study.
Mazzilli S; Garofalo V; Ventura A; Diluvio L; Milani M; Bianchi L; Campione E
Clin Cosmet Investig Dermatol; 2018; 11():485-490. PubMed ID: 30349346
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study.
Babino G; Diluvio L; Bianchi L; Orlandi A; Di Prete M; Chimenti S; Milani M; Campione E
Curr Med Res Opin; 2016 Aug; 32(8):1345-9. PubMed ID: 27046744
[TBL] [Abstract][Full Text] [Related]
6. Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.
Malvehy J; Alarcon I; Montoya J; Rodríguez-Azeredo R; Puig S
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):258-65. PubMed ID: 26538346
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial.
Puviani M; Milani M
Dermatol Ther (Heidelb); 2018 Sep; 8(3):399-404. PubMed ID: 29855896
[TBL] [Abstract][Full Text] [Related]
9. Dermoscopy and Reflectance Confocal Microscopy in Actinic Keratosis, Intraepithelial Carcinoma, and Invasive Squamous Cell Carcinoma.
Rstom S; Abdalla B; Blumetti T; Matos L; Pinhal M; Paschoal F
J Drugs Dermatol; 2022 Mar; 21(3):259-268. PubMed ID: 35254762
[TBL] [Abstract][Full Text] [Related]
10. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
[TBL] [Abstract][Full Text] [Related]
11. Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy.
Cavalcante RBM; Valente NYS; Ferreira PS; Neto CF; Torezan L
Eur J Dermatol; 2023 Dec; 33(6):674-679. PubMed ID: 38465549
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer.
Puviani M; Barcella A; Milani M
G Ital Dermatol Venereol; 2013 Dec; 148(6):693-8. PubMed ID: 24442053
[TBL] [Abstract][Full Text] [Related]
13. In vivo confocal microscopy efficacy assessment of daylight photodynamic therapy in actinic keratosis patients.
Seyed Jafari SM; Timchik T; Hunger RE
Br J Dermatol; 2016 Aug; 175(2):375-81. PubMed ID: 26949030
[TBL] [Abstract][Full Text] [Related]
14. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases.
Garofalo V; Ventura A; Mazzilli S; Diluvio L; Bianchi L; Toti L; Tisone G; Milani M; Campione E
Case Rep Dermatol; 2017; 9(3):211-216. PubMed ID: 29282394
[TBL] [Abstract][Full Text] [Related]
16. Histopathology and reflectance confocal microscopy features of photodamaged skin and actinic keratosis.
Tan JM; Lambie D; Sinnya S; Sahebian A; Soyer HP; Prow TW; Ardigò M
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):1901-1911. PubMed ID: 27298142
[TBL] [Abstract][Full Text] [Related]
17. Treatment monitoring of 5-fluorouracil 0.5%/salicylic acid 10% lesion-directed therapy for actinic keratosis using dermoscopy and in-vivo reflectance confocal microscopy.
Pampena R; Condorelli A; Cornacchia L; Guiducci L; Raucci M; Benati E; Mirra M; Peris K; Lai M; Pellacani G; Longo C
Dermatol Ther; 2020 Jul; 33(4):e13744. PubMed ID: 32478958
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi Sarcoma.
Scotti E; Deledda S; Milani M
Case Rep Dermatol; 2016; 8(3):254-261. PubMed ID: 28101017
[TBL] [Abstract][Full Text] [Related]
19. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses.
Ulrich M; Krueger-Corcoran D; Roewert-Huber J; Sterry W; Stockfleth E; Astner S
Dermatology; 2010; 220(1):15-24. PubMed ID: 19907131
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.
Campione E; Diluvio L; Paternò EJ; Chimenti S
Am J Clin Dermatol; 2010; 11(1):45-50. PubMed ID: 20000874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
